Skip to main content
. 2021 Jan 21;106(3):664–670. doi: 10.3324/haematol.2019.240747

Table 1.

Important characteristics of FLT3 kinase inhibitor therapy in acute myeloid leukemia.

graphic file with name 106664.tab1.jpg